Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours

Oncology Reports

Volumn 10, Issue 2, 2003, Pages 277-283

  Uemura, Kenichiro ^a   Hiyama, Eiso ^a   Murakami, Yoshiaki ^a   Kanehiro, Tetsuya ^a   Ohge, Hiroki ^a   Sueda, Taijiro ^a   Yokoyama, Takashi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Intraductal papillary mucinous tumour; K ras point mutation; p53 over expression; Pancreatic ductal adenocarcinoma; Telomerase activity

Indexed keywords

PROTEIN P53; TELOMERASE; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CYSTADENOMA; ENZYME IMMUNOASSAY; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEOPLASM; ONCOGENE RAS; PANCREAS CARCINOMA; PANCREAS TUMOR; PANCREATITIS; PAPILLARY CARCINOMA; PATHOLOGY; POINT MUTATION; PROGNOSIS; UPREGULATION;

ADOLESCENT; ADULT; AGED; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; CYSTADENOMA, PAPILLARY; FEMALE; GENES, RAS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; PANCREATIC NEOPLASMS; PANCREATITIS; POINT MUTATION; PROGNOSIS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0037771488     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.2.277     Document Type: Article

References (30)

1. Tada M, Omata M, Kawai S, Saisho H, Ohto M, Saiki RK and Sninsky JJ: Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 53: 2472-2474, 1993. (Pubitemid 23168007)
2. Iguchi H, Sugano K, Fukayama N, Ohkura H, Sadamoto K, Ohkoshi K, Seo Y, Tomoda H, Funakaoshi A and Wakasugi H: Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer. Gastroenterology 110: 221-226, 1996. (Pubitemid 26021621)
3. Nakamura Y, Onda M and Uchida E: Analysis of K-ras codon 12 point mutations using duodenal lavage fluid for diagnosis of pancreatic carcinoma. Pancreas 18: 133-140, 1999. (Pubitemid 29180109)
4. Ishimaru S, Itoh M, Hanada K, Tsuchida A, Iwao T and Kajiyama G: Immunocytochemical detection of p53 protein from pancreatic duct brushings in patients with pancreatic carcinoma. Cancer 77: 2233-2239, 1996. (Pubitemid 26162414)
5. Iwao T, Hanada K, Tsuchida A, Hirata M, Eguchi N and Kajiyama G: The establishment of a preoperative diagnosis of pancreatic carcinoma using cell specimens from pancreatic duct brushing with special attention to p53 mutations. Cancer 82: 1487-1494, 1998. (Pubitemid 28164994)
6. Iwao T, Hiyama E, Yokoyama T, Tsuchida A, Hiyama K, Murakami Y, Shimamoto F, Shay JW and Kajiyama G: Telomerase activity for the preoperative diagnosis of pancreatic cancer. J Natl Cancer Inst 89: 1621-1623, 1997. (Pubitemid 27479723)
7. Suehara N, Mizumoto K, Tanaka M, Niiyama H, Yokohata K, Tominaga Y, Shimura H, Muta T and Hamasaki N: Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis. Clin Cancer Res 3: 2479-2483, 1997. (Pubitemid 28133171)
8. Uehara H, Nakazumi A, Tatsuta M, Baba M, Takenaka A, Uedo N, Sakai N, Yano H, Iishi H, Ohigashi H, Ishikawa O, Okada S and Kakizoe T: Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations. Am J Gastroenterol 94: 2513-2518, 1999. (Pubitemid 29420682)
9. Hiyama E, Kodama T, Shinbara K, Iwao T, Itoh M, Hiyama K, Shay JW, Matsuura Y and Yokoyama T: Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res 57: 326-331, 1997. (Pubitemid 27036614)
10. Solcia E, Capella C and Kloppel G: Tumors of the pancreas. In: Atlas of Tumor Pathology. AFIP, Washington DC, 1997.
11. Sobin LH and Wittekind CH: UICC TNM Classification of Malignant Tumors. 5th edition. Wiley-Liss, New York, 1997.
12. Takeda S, Ichii S and Nakamura Y: Detection of K-ras mutation in sputum by mutant-allele-specific amplification (MASA). Hum Mutat2: 112-117, 1993. (Pubitemid 23170970)
13. Inoue S, Tezel E and Nakao A: Molecular diagnosis of pancreatic cancer. Hepatogastroenterology 48: 933-938, 1997. (Pubitemid 32757714)
14. Hruban RH, Iacobuzio-Donahue C, Wilentz RE, Goggins M and Kern SE: Molecular pathology of pancreatic cancer. Cancer J 7: 251-258, 2001.
15. Kiaris H and Spandidos DA: Mutations of ras genes in human tumours (review). Int J Oncol 7: 413-421, 1995.
16. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N and Perucho M: Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53: 549-554, 1988.
17. Smit VT, Boot AJ, Smits AM, Fleuren GJ, Cornelisse CJ and Bos JL: KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res 16: 7773-7782, 1998.
18. Grunewald K, Lyons J, Frolich A, Feichtinger H, Weger RA and Schwab G: High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer 43: 1037-1041, 1989. (Pubitemid 19158034)
19. Tada M, Omata M and Ohto M: Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma. Gastroenterology 100:233-238, 1991.
20. Tada M, Ohashi M, Shiratori Y, Okudaira T, Komatsu Y and Kawabe T: Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology 110: 227-231, 1996. (Pubitemid 26021622)
21. Yanagisawa A, Ohtake K, Ohashi K, Hori M, Kitagawa T and Sugano H: Frequent c-Ki-ras oncogene activation in mucous cell hyperplasia of pancreas suffering from chronic inflammation. Cancer Res 53: 953-956, 1993. (Pubitemid 23087890)
22. Caldas C, Hahn SA, Hruban RH, Redston MS, Yeo CJ and Kern SE: Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 54: 3568-3573, 1994. (Pubitemid 24225985)
23. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, Dimagno EP, Andren-Sandberg A and Domeilof L: Pancreatitis and the risk of pancreatic cancer. N Engl J Med 328: 1433-1437, 1993. (Pubitemid 23143844)
24. Queneau PE, Adessi GL, Thibault P, Cleau D, Heyd B, Mantion G and Carayan P: Early detection of pancreatic cancer in patients with chronic pancreatitis. Diagnostic utility of a K-ras point mutation in the pancreatic juice. Am J Gastroenterol 96: 700-704, 2001. (Pubitemid 32240718)
25. Hiyama E and Hiyama K: Clinical utility of telomerase in cancer. Oncogene 21: 643-649, 2002. (Pubitemid 34146266)
26. Hiyama K, Hirai Y, Kyouizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S and Yamakido M: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155: 3711-3715, 1995.
27. Hiyama E, Hiyama K, Tatsumoto N, Kodama T, Shay JW and Yokoyama T: Telomerase activity in human intestine. Int J Oncol 9: 453-458, 1996. (Pubitemid 26323934)
28. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA and Shay JW: Detection of telomerase activity in malignant and non-malignant skin condition. J Invest Dermatol 106: 759-765, 1996. (Pubitemid 26120582)
29. Scarpa A, Capelli P, Mukai K, Zamboni G, Oda T, Lacono C and Hirohashi S: Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol 142: 1534-1543, 1993. (Pubitemid 24058140)
30. Konishi Y, Tsutsumi M and Tsujiuchi T: Mechanistic analysis of pancreatic ductal carcinogenesis in hamsters. Pancreas 16: 300-306, 1998. (Pubitemid 28158032)